Showing results (11-20 of 248) with videos related to
Sort By:
Pageof 25
Journal of Medicinal Chemistry|February 4, 2005
Modeling the similarity and divergence of dopamine D2-like receptors and identification of validated ligand-receptor complexesFrank Boeckler, Harald Lanig, Peter GmeinerBioorganic & Medicinal Chemistry|June 2, 2019
Development of covalent antagonists for β1- and β2-adrenergic receptorsTobias Schwalbe, Harald Huebner, Peter GmeinerJournal of Medicinal Chemistry|October 8, 2009
1,1'-Disubstituted ferrocenes as molecular hinges in mono- and bivalent dopamine receptor ligandsDaniela Huber, Harald Hübner, Peter GmeinerThe Journal of Organic Chemistry|January 8, 2003
A general approach to dehydro-Freidinger lactams: ex-chiral pool synthesis and spectroscopic evaluation as potential reverse turn inducersTobias Hoffmann, Reiner Waibel, Peter GmeinerBioorganic & Medicinal Chemistry Letters|August 6, 2002
Fused azaindole derivatives: molecular design, synthesis and in vitro pharmacology leading to the preferential dopamine D3 receptor agonist FAUC 725Stefan Löber, Harald Hübner, Peter GmeinerBioorganic & Medicinal Chemistry Letters|March 6, 2003
Cyclic amidines as benzamide bioisosteres: EPC synthesis and SAR studies leading to the selective dopamine D4 receptor agonist FAUC 312Jürgen Einsiedel, Harald Hübner, Peter GmeinerACS Chemical Neuroscience|July 11, 2012
Cross-receptor interactions between dopamine D2L and neurotensin NTS1 receptors modulate binding affinities of dopaminergicsSusanne Koschatzky, Nuska Tschammer, Peter GmeinerOrganic Letters|May 9, 2003
Click linker: efficient and high-yielding synthesis of a new family of SPOS resins by 1,3-dipolar cycloadditionStefan Löber, Pilar Rodriguez-Loaiza, Peter GmeinerPlos One|January 8, 2016
Comparative MD Simulations Indicate a Dual Role for Arg1323.50 in Dopamine-Dependent D2R ActivationRalf C Kling, Timothy Clark, Peter GmeinerBioorganic & Medicinal Chemistry|December 31, 2003
Analogues of FAUC 73 revealing new insights into the structural requirements of nonaromatic dopamine D3 receptor agonistsCarola Lenz, Frank Boeckler, Harald Hübner, et al.Pageof 25